Science & Enterprise subscription

Follow us on Twitter

  • A software package using an image-aided form of machine learning can quickly identify and classify tumor from other… https://t.co/U4wWfNNm6j
    about 32 mins ago
  • New post on Science and Enterprise: A.I. Harnessed to Detect Cancer Cells https://t.co/WAcmQMsOCe #Science #Business
    about 35 mins ago
  • Growth patterns in the U.S. show a concentration of technology development in a few cities, with new policies and i… https://t.co/MhS25iyLfB
    about 1 day ago
  • Many thanks @SciSeeker ... much appreciated https://t.co/IW2mhV5F8E
    about 1 day ago
  • New post on Science and Enterprise: Report – U.S. Needs Regional Technology Centers https://t.co/rn5v6k5qdJ #Science #Business
    about 1 day ago

Please share Science & Enterprise

Patent Awarded for Synthetic Canine Antimicrobial Peptide

Dog with mouth open (Randy Robertson/Flickr)Kansas State University in Manhattan says a team of its researchers has received a U.S. patent for their discovery of a synthetic peptide that helps dogs better fight pathogens, such as bacteria, viruses and fungi. The patent, “Antimicrobial Cathelicidin Peptides” was awarded by the U.S. Patent and Trademark Office to K-State nutritionist Tonatiuh Melgarejo, immunophysiologist Frank Blecha, and former postdoctoral fellows Yongming Sang and Maria Ortega.

Peptides are small molecules that kill microbes like bacteria, viruses and yeast. The researchers used the canine genome to isolate a cathelicidin peptide found in the white blood cells of dogs. Cathelicidin peptides play a key role in early innate immunity against infections.

Different animal species, says Melgarejo, produce different antimicrobial peptides built into their DNA. Dogs have only one type of cathelicidin peptide — an indication of the peptide’s power — which led the researchers to focus on that peptide in dogs. And they modeled the properties of the naturally occurring peptide to create the synthetic version.

Despite the presence of this natural peptide, dogs still suffer from infections, which the synthetic peptide can help treat. “When I worked in the clinical sciences, I regularly treated dogs for diarrhea, coughing, ear infections, dermatitis, conjunctivitis and other diseases,” says Melgarejo. “So it’s evidently not as sturdy of an animal as it could be.”

Melgarejo, Blecha, and other K-State colleagues are further developing this synthesized cathelicidin by studying the hyena, considered one of the most resilient animals in nature. They also plan to test the synthesized peptide against canine leishmaniasis, a tropical disease that spreads from dogs to humans.

Read more:

Photo: Randy Robertson/Flickr

*     *     *

Please share Science & Enterprise ...
error

Comments are closed.